Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04436809
What this trial is testing

Sentinel Node Biopsy Alone or With Axillary Dissection After Primary Chemotherapy

Who this might be right for
Breast Neoplasm Female
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 353
Not applicableEnded earlyNCT02614157
What this trial is testing

Lateral Lymph Node Dissection After Neoadjuvant Chemo-radiation in Advanced Low Rectal Cancer

Who this might be right for
Rectal Cancer
West China Hospital 51
Post-approval studies (Phase 4)Study completedNCT03805607
What this trial is testing

IV Ketorolac on Platelet Function Post-Cesarean Delivery

Who this might be right for
Analgesia, ObstetricalCoagulation Defect; PostpartumNonsteroidals (NSAIDs)Toxicity+4 more
Beth Israel Deaconess Medical Center 40
Not applicableLooking for participantsNCT06632093
What this trial is testing

HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLC

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaHepatic Arterial Infusion Chemotherapy+3 more
First Hospital of China Medical University 84
Testing effectiveness (Phase 2)Study completedNCT01348412
What this trial is testing

Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure

Who this might be right for
Colorectal CancerLiver Metastases
Centre Georges Francois Leclerc 31
Not applicableLooking for participantsNCT07353099
What this trial is testing

A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With Adzynma

Who this might be right for
Thrombotic Thrombocytopenic Purpura (TTP)
Takeda 50
Early research (Phase 1)WithdrawnNCT03045393
What this trial is testing

Mirvetuximab Soravtansine (IMG853) in Folate Receptor Alpha-expressing TNBC

Who this might be right for
Breast Cancer Triple Negative
Duke University
Testing effectiveness (Phase 2)Ended earlyNCT02654639
What this trial is testing

Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Georgetown University 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07743541
What this trial is testing

Study of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After Chemotherapy and Immune Therapy

Who this might be right for
Uterine Endometrial Cancer
Tubulis GmbH 100
Early research (Phase 1)Study completedNCT00012207
What this trial is testing

Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Fred Hutchinson Cancer Center 12
Not applicableWithdrawnNCT03138395
What this trial is testing

ICare3: Monitoring Circulating Cancer DNA After Chemotherapy in MDS and AML

Who this might be right for
Acute LeukemiaMyelodysplastic SyndromesAML+1 more
University of Florida
Testing effectiveness (Phase 2)Study completedNCT00635193
What this trial is testing

Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)

Who this might be right for
Ovarian Cancer, Primary Peritoneal Cancer
AbbVie (prior sponsor, Abbott) 138
Not applicableNot Yet RecruitingNCT07372521
What this trial is testing

Measuring Small-Airways Disease Improvement After Step-up to Extrafine TRIple or High-dose ICS/LABA in Patients Uncontrolled on Medium Dose ICS/LABA eXploring T2 Inflammation

Who this might be right for
Asthma
University Hospital, Ioannina 130
Large-scale testing (Phase 3)UnknownNCT03598348
What this trial is testing

Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Huazhong University of Science and Technology 288
Large-scale testing (Phase 3)Active Not RecruitingNCT06211764
What this trial is testing

TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)

Who this might be right for
Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC 272
Not applicableEnrolling By InvitationNCT06828614
What this trial is testing

Barriers to Therapeutic Exercise in Breast Cancer Patients Before, During, and After Chemotherapy

Who this might be right for
Breast Cancer
University of Valencia 111
Testing effectiveness (Phase 2)Study completedNCT01816971
What this trial is testing

Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
University of Chicago 76
Large-scale testing (Phase 3)UnknownNCT00180934
What this trial is testing

Reirradiation With Concomitant Chemotherapy After Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area

Who this might be right for
Recurrence of Head and Cancer in Irraiated Area
Gustave Roussy, Cancer Campus, Grand Paris 280
Testing effectiveness (Phase 2)Study completedNCT00901147
What this trial is testing

Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma (Not Otherwise Specified)Angioimmunoblastic T-cell LymphomaExtranodal NK/T-cell Lymphoma Nasal Type+4 more
Singapore General Hospital 25
Testing effectiveness (Phase 2)UnknownNCT04989322
What this trial is testing

Pembrolizumab, Lenvatinib and Chemotherapy After TKIs in NSCLC

Who this might be right for
NsclcEGFR Activating MutationEGF-R Positive Non-Small Cell Lung Cancer+3 more
Dr Joanne CHIU 46
Next Page